Patents expiring in 2036

US 9527887

Treatments for gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9526799

Low density lipoprotein receptor-mediated siRNA delivery

Arrowhead Pharmaceuticals, Inc. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9528109

Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9529005

Modulating bacterial MAM polypeptides in pathogenic disease

The Board of Regents of the University of Texas System · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9529001

Methods of diagnosing and treating autism

The Regents of the University of California · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9528094

Attenuated African swine fever virus vaccine based in the deletion of MGF genes

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9528994

Target of the phosphoinositide 3-kinase pathway

The Regents of the University of California · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9527919

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

The Regents of the University of California · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2985531

COMPOSITION DEODORANTE COMPRENANT UN MELANGE D'ALPHA-, BETA- ET GAMMA- CYCLODEXTRINE

ACRAF [IT] · Granted Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2016209959

COMBINAISONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX POLLEN DE CÈDRE

ALK-ABELLÓ AS [DK] · Granted Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

CH 711279

Verpacktes Arzneimittel, umfassend eine Retardformulierung von Naloxon oder einem pharmazeutisch verträglichen Salz davon, und eine Verpackung.

ACINO PHARMA AG [CH] · Granted Fri Dec 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533990

Inhibitors of secretion of hepatitis B virus antigens

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532998

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532989

Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532994

Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533039

Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533025

Method for treating chemotherapy-induced male infertility

The Board of Regents of the University of Texas System · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534220

Antisense antibacterial method and compound

Sarepta Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532555

Humanized dipeptidyl peptidase IV (DPP4) animals

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534277

Method for purification of 225AC from irradiated 226RA-targets

Actinium Phamaceuticals, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533962

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534033

Targeted interferons demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534041

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534008

Small molecule compounds that control plant- and insect-pathogenic nematodes

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534007

Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533987

Heterocyclic derivates

KalVista Pharmaceuticals Limited · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533981

Pyridine derivatives

Asana BioSciences, LLC · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533045

Photothermal therapy using magnetic nanoparticles

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533947

Benzamide compounds and related methods of use

Northwestern University · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533966

Cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533031

Yeast-MUC1 immunotherapeutic compositions and uses thereof

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534044

Alpha-synuclein antibodies and uses thereof

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9535076

Methods and compositions for eliciting an amyloid-selective immune response

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533014

Synergistic bacterial compositions and methods of production and use thereof

Seres Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532948

Nanostructure suitable for sequestering cholesterol and other molecules

Northwestern University · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017004561

ASSOCIATIONS DE PEPTIDES ET LEURS UTILISATIONS DANS LE TRAITEMENT DE L'ALLERGIE AUX GRAMINÉES

ALK-ABELLÓ AS [DK] · Granted Thu Jan 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)